Reduced pre-pregnancy proteinuria is associated with improving postnatal maternal renal outcomes in iga nephropathy women

Clinical Nephrology

Volumn 76, Issue 6, 2011, Pages 447-454

  Oh, H J ^a   Han, S H ^a   Yoo, D E ^a   Kim, S J ^a   Park, J T ^a   Kim, J K ^a   Yoo, T H ^a   Kang, S W ^a   Choi, K H ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Immunoglobulin A (IgA) nephropathy; Pregnancy; Proteinuria renal disease progression

Indexed keywords

CREATININE;

ADULT; ARTICLE; CESAREAN SECTION; CONCEPTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTNATAL CARE; PREGNANCY DISORDER; PREMATURE LABOR; PROTEINURIA; RETROSPECTIVE STUDY;

ADULT; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HUMANS; INFANT, NEWBORN; KIDNEY; PREGNANCY; PREGNANCY COMPLICATIONS; PROTEINURIA; RETROSPECTIVE STUDIES;

EID: 84855425513     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107208     Document Type: Article

References (24)

1. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol. 2005; 16: 2088-2097.
2. Packham DK, North RA, Fairley KF, Whitworth JA, Kincaid-Smith P. IgA glomerulonephritis and pregnancy. Clin Nephrol. 1988; 30: 15-21.
3. Jungers P, Houillier P, Forget D, Labrunie M, Skhiri H, Giatras I, Descamps-Latscha B. Influence of pregnancy on the course of primary chronic glomerulonephritis. Lancet. 1995; 346: 1122-1124.
4. Abe S. The influence of pregnancy on the longterm renal prognosis of IgA nephropathy. Clin Nephrol. 1994; 41: 61-64.
5. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis. 2001; 38: 728-735.
6. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Nephrol Dial Transplant. 2002; 17: 1197-1203.
7. Reich HN, Troyanov S, Scholey JW, Cattran DC; Toronto Glomerulonephritis Registry. Remission of proteinuria improves prognosis in IgA nephropathy. J Am Soc Nephrol. 2007; 18: 3177-3183.
8. Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a longterm follow up of 204 cases in China. Nephrology (Carlton). 2008; 13: 242-246.
9. Coppo R, D'Amico G. Factors predicting progression of IgA nephropathies. J Nephrol. 2005; 18: 503-512.
10. Kincaid-Smith P, Fairley KF. Renal disease in pregnancy. Three controversial areas: mesangial IgA nephropathy, focal glomerular sclerosis (focal and segmental hyalinosis and sclerosis), and reflux nephropathy. Am J Kidney Dis. 1987; 9: 328-333.
11. Hemmelder MH, de Zeeuw D, Fidler V, de Jong PE. Proteinuria: a risk factor for pregnancy-related renal function decline in primary glomerular disease? Am J Kidney Dis. 1995; 26: 187-192.
12. Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L. Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol. 2011; 22: 752-761.
13. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39 (Suppl 1): S1-S266.
14. Imbasciati E, Gregorini G, Cabiddu G, Gammaro L, Ambroso G, Del Giudice A, Ravani P. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis. 2007; 49: 753-762.
15. Piccoli GB, Attini R, Vasario E, Conijn A, Biolcati M, D'Amico F, Consiglio V, Bontempo S, Todros T. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol. 2010; 5: 844-855.
16. Franceschini N, Savitz DA, Kaufman JS, Thorp JM. Maternal urine albumin excretion and pregnancy outcome. Am J Kidney Dis. 2005; 45: 1010-1018.
17. Zappitelli M, Zhang X, Foster BJ. Estimating glomerular filtration rate in children at serial followup when height is unknown. Clin J Am Soc Nephrol. 2010; 5: 1763-1769.
18. Poon LC, Kametas N, Bonino S, Vercellotti E, Nicolaides KH. Urine albumin concentration and albumin-to-creatinine ratio at 11(+0) to 13(+6) weeks in the prediction of pre-eclampsia. BJOG. 2008; 115: 866-873.
19. Bar J, Hod M, Erman A, Friedman S, Gelerenter I, Kaplan B, Boner G, Ovadia J. Microalbuminuria as an early predictor of hypertensive complications in pregnant women at high risk. Am J Kidney Dis. 1996; 28: 220-225.
20. Gordon M, Landon MB, Samuels P, Hissrich S, Gabbe SG. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol. 1996; 87: 401-409.
21. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345: 861-869.
22. Atkins RC, Briganti EM, Lewis JB, Hunsicker LG, Braden G, Champion de Crespigny PJ, DeFerrari G, Drury P, Locatelli F, Wiegmann TB, Lewis EJ. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis. 2005; 45: 281-287.
23. de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int. 2004; 65: 2309-2320.
24. Rodriguez-Thompson D, Lieberman ES. Use of a random urinary protein-to-creatinine ratio for the diagnosis of significant proteinuria during pregnancy. Am J Obstet Gynecol. 2001; 185: 808-811.